Category: Disease States

Disease States

A new study identifies three sepsis subtypes and highlights ELL2 as a promising biomarker for early diagnosis and prognosis.

AI-enhanced EEG technology offers a promising, accessible way to detect early signs of Alzheimer’s disease—years before symptoms appear.

Diagnosing lupus remains a major challenge, but emerging biomarkers offer significant promise in improving early and accurate detection.

A new prospective study in BMC Cancer shows that the blood-based multi-omics test SeekInClarity accurately predicts treatment outcomes.

Researchers have developed a handheld TB test that accurately detects tuberculosis in HIV-positive individuals using a single drop of blood.

Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.

A new peer-reviewed study validates Vibrant Sciences’ microarray, enabling fast, accurate, scalable detection of over 17 tickborne pathogens.

University of Tokyo researchers have developed a non-invasive, AI-powered imaging system that tracks platelet activity in real time.

Quanterix Corporation's HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration in South Korea.

Two studies demonstrate how AI models can significantly improve early detection of type 1 diabetes, enabling earlier intervention.

A pilot program using Healthy.io’s FDA-cleared smartphone-powered Minuteful Kidney test significantly improved CKD screening and diagnosis.

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Researchers propose developing tiny chemical sensors that detect VOCs in bodily fluids to rapidly diagnose bacterial infections.